Pediatric Clinics of North America 1996: Vol 43 Index

33 Pages·1996·7 MB·English

CUMULATIVE INDEX 1996
Volume4 3
February PEDIATRIC GASTROENTEROLOGY I, pages 1-305
April PEDIATRIC GASTROENTEROLOGY II, pages 307-598
June PEDIATRIC HEMATOLOGY, pages 599--828
August COMMON ORTHOPEDIC PROBLEMS I, pages 829-989
October COMMON ORTHOPEDIC PROBLEMS II, pages 991-1163
December PEDIATRIC OTOLARYNGOLOGY, pages 1165-1459
Note: Page numbers of article and issue titles are in boldface type
Abdominal pain, functional, gas formation Adenoidectomy, with tonsillectomy,
and, 494-495 1319-1338
in Caroli’s disease, 83 for sinusitis, 1308
in human immunodeficiency virus infec- indications for, 1320-1324
tion, 584 adenotonsillar hypertrophy with
Abetalipoproteinemia, and chronic upper airway obstruction,
diarrhea, 319-320 1322-1323
Abscess rupture, with deep neck infection, eating /swallowing disorders, 1323
1283 obstructive sleep apnea, 1321-1322
Absorption, mechanism of, 307-308 orofacial growth abnormalities and
Accessory navicular, and foot deformity, dental malocclusion, 1323
1105 recurrent throat infections, 1321
Acetabular dysplasia, radiography of, speech abnormalities, 1323
843-844, 846 suspicion of malignancy, 1323
Acetabular index, in radiography of without tonsillectomy, indications for,
developmental hip dysplasia, 837 1325-1326 j
Achilles tendonitis, with repetitive Adenotonsillar hypertrophy, infectious
overuse, 1016 mononucleosis with, 1327
Acquired immunodeficiency syndrome with upper airway obstruction, adenoid-
(AIDS), gastrointestinal and ectomy/tonsillectomy for, 1322-
nutritional problems in, 573-590 1323
Acrodermatitis enteropathica, and chronic Adenotonsillectomy, alternatives to, 1326
diarrhea, 320-321 contraindications to, 1328
Activated charcoal, for gastrointestinal gas, laboratory studies for, 1328-1329
503 postoperative complications of, 1331-
Acute chest syndrome, in sickle cell 1332
disease, 649-651 postoperative course of, 1330-1331
Acute transient synovitis, and hip pain, surgical techniques for, 1330
1053-1056 Adenoviruses, for cystic fibrosis gene
Acyclovir, for recurrent respiratory therapy, 190
papillomatosis, 1395 Adolescents, back pain in, 899-917. See
Adams forward bend test, for spinal also Back pain.
deformity, 888-889 Adrenal insufficiency, and chronic
Adenoid(s), prominent, 1307 diarrhea, 322
1430 CUMULATIVE INDEX 1996
Aerodigestive foreign bodies, computer in parvovirus B19 infection, 812-813
simulation of, 1408-1409 macrocytic, 606-607
cumulative percentage of, 1404 mean corpuscular hemoglobin concentra-
diagnostic evaluation of, 1405-1406 tion in, 608-609
disease progression in, 1406-1408 microcytic, 607-608
endoscopy and bronchoscopy in, 1408- of chronic disease in adults, 624-626
1410 of infancy, physiologic, 612-614
future safety goals for, 1410-1411 of inflammation, 623-637
injuries by, prevention and management differential diagnosis of, 632-633
of, 1403-1411 evaluation of, 632-633
radiologic studies of, 1406 pathophysiology of, 629-632
Aeromonas, and secretory diarrhea, 341 cytokines, 631-632
Agranulocytosis, congenital, 781-783 decreased red blood cell survival,
clinical features of, 781-782 629-630
laboratory studies of, 782 hypoferremia, 630
pathophysiology of, 782 impaired iron release, 630
treatment of, 782-783 ineffective bone marrow response,
AIDS, gastrointestinal and nutritional 630-631
problems in, 573-590 treatment of, 633-634
Air swallowing, and gastrointestinal gas Aneurysmal bone cyst, 962-963
accumulation, 490, 495-497 and back pain, 915
Airway compromise, with deep neck Angular deformities, 867-881
infection, 1283 Angular malalignment, 874-880
Alagille’s syndrome, 85-86 evaluation of, 875-877
chronic cholestasis with, 18-20 imaging studies of, 877-878
Albright’s syndrome, polyostotic fibrous management of, 878-880
dysplasia in, 960 natural history of, 874-875
Alfa-interferon, for recurrent respiratory Angulation, risk of, with femoral shaft
papillomatosis, 1394-1395 fracture, 1006
Alkaline phosphatase, elevated, in Ankle, disorders of, with cerebral palsy,
cholestasis, 10, 85 orthopedic surgery for, 1144
Alpha globulin genes, organization of, 668 fracture of, 1009-1011, 1107
Alpha-thalassemia syndromes, in sprains of, 1107
Southeast Asian children, 667-671 Anorectal disorders, fecal incontinence
alpha-thalassemia state, 669 with, 286-287
hemoglobin H disease, 669-670 Anoxia, and cerebral palsy, 1136
homozygous alpha-thalassemia, and sensorineural hearing loss, 1210-
670-671 1211
silent carrier state, 668 Antacids, for gastroesophageal reflux, 208
Alveolar rhabdomyosarcoma, bone lesions Anterior cricoid split, for laryngotracheal
with, 982 stenosis, 1421-1422
Ambulators, with cerebral palsy, Anterior cruciate ligament, injuries of,
management of, 1145-1147 1086-1087
Amebiasis, and chronic diarrhea, 311 Anterior visceral space, deep infection of,
Amenorrhea, in Wilson's disease, 29 1293-1295
Aminoglycosides, and sensorineural Anti-D immunoglobulin, intravenous, for
hearing loss, 1209 idiopathic thrombocytopenic purpura,
5-Aminosalicylate agents, for Crohn's 760-761
disease, 271 Antibiotics, for acute hematogenous
Amoxicillin, for otitis media, 1169-1170 osteomyelitis, 941
Amylase, congenital deficiency of, and for Crohn’s disease, 272
pancreatic insufficiency, 134 for otitis media, selection of, 1169-1171
serum/urine, in acute pancreatitis, 140- Antifibrolytic therapy, for hemophilia,
141 720-721
Anatomic lesions, and chronic diarrhea, Antigenic absorption, intestinal, barriers
325 to, 557
Anemia, classification of, based on red cell Antilymphocyte globulin, for liver
indices, 605 transplantation, 113
evaluation of, 604-609 Antimalarials, and sensorineural hearing
in newborns, 610 loss, 1210
CUMULATIVE INDEX 1996 1431
Antimicrobial therapy, for sinusitis, 1305 in children and adolescents, 899-917
Antineutrophil antibodies, in chronic differential diagnoses in, 900
neutropenia, 778 history of, 900-902
Antioxidants, 471-488 physical examination in, 902-903
defenses by, 475-477 radiography of, 903-904
enzymatic, 475-476 treatment of, 912
in cystic fibrosis, 483-484 tumors and, 913, 914
in pancreatitis, 483 Bacteria, and secretory diarrhea, 335-341
nutritional, 476-477 Aeromonas, 341
soluble, 476 Bacillus, 341
synthetic, 477 Campylobacter, 339-340
therapeutic, ideal, 477-478 Clostridium, 340-341
transition metal sequestration by, 477 Escherichia coli, 336-338
Antithymocyte globulin, for liver Plesiomonas, 341
transplantation, 113 Salmonella, 338, 341
a,-Antitrypsin deficiency, 41-44 Shigella, 338-339
Aplastic crisis, in parvovirus B19 infection, Staphylococcus, 341
814 Vibrio, 335-336
Apnea, with gastroesophageal reflux, 200 Yersinia, 339-340
Arteriohepatic dysplasia, 85-86 Bacterial adherence, and mucosal
Arthritis, septic, 942-946 immunity, 561-562
diagnosis of, 944-945 Bacterial overgrowth, in short bowel
etiology by decade, 945 syndrome, long-term management of,
joint involvement in, 943 540-541
signs and symptoms of, 943-944 Bacteroides fragilis, and gastroenterocolitis,
treatment of, 946 396-397
with ulcerative colitis, 238 Barium swallow, in gastroesophageal
Arthrogryposis multiplex congenita, with reflux, 201-202
congenital neuromuscular disorders, Basilar impression, 925-926
1131 Beano, for gastrointestinal gas, 503
Articular malalignment, with repetitive Benign bone tumors, 949-966. See also
overuse, 1017-1020 Bone tumors.
Articulation disorders, 1375-1376 Bernard-Soulier syndrome, giant platelets
Arytenoid surgery, for vocal fold in, 742
paralysis, 1370 Beta-thalassemia disorders, in Southeast
Aspiration, computer simulation of, Asian children, 672-673
1408-1409 Bethanochol, for gastroesophageal reflux,
Asplenia, functional, in sickle cell disease, 208
644-647 Bicarbonate, intestinal absorption of,
Asthma, with gastroesophageal reflux, 200 437-438
Astrovirus, and gastroenterocolitis, 397 intestinal secretion of, physiology of,
Atlantoaxial instability, 924-925 438-439
Atlantoaxial rotatory subluxation, 923-924 Bile acid synthesis, errors of, 21-22
Aural atresia, pediatrician’s management Bile ducts, diseases of, 75-89
of, 1241-1244 inflammation of, 15-17
Autoimmune enteropathy, and chronic interlobular, paucity of, 20
diarrhea, 319 intrahepatic, segmental saccular dilata-
Azathioprine, for liver transplantation, 113 tion of, 83-84
for ulcerative colitis, 247 intralobular, paucity of, 84-86
Azithromycin, for otitis media, 1170 Bile retention, with cholestasis, 4
Bile salts, deficiency of, in acute diarrhea,
442
increased, with cholestasis, 5
Bacillus, and secretory diarrhea, 341 Biliary atresia, 13-15, 75-79
Back pain, aneurysmal bone cyst and, 915 diagnosis of, 14-15
clinical findings in, 908-912 extrahepatic, 75-79
bone scans, 910-912 etiology of, 76-77
radiographic, 908-910 pathology in, 77
disc problems and, 904-907. See also prognosis in, 78-79
Disc problems. site of obstruction in, 78
1432 CUMULATIVE INDEX 1996
Biliary atresia (Continued) Bone marrow, examination of, in chronic
laboratory evaluation of, 14, 76 neutropenia, 777
liver transplantation for, 79, 102-103 failure of, and anemia, 606-607
presentation of, 14 ineffective response of, in anemia of in-
treatment of, 15 flammation, 630-631
Biliary cirrhosis, in cystic fibrosis, 177-179 transplantation of, for congenital agranu-
progressive, with extrahepatic biliary locytosis, 782
atresia, 75 for sickle cell disease, 657-658
Biliary diversion, for Alagille’s syndrome, Bone pain, in osteomyelitis, 935
19 Bone shortening, for limb length
Biliary excretory scan, in cholestasis discrepancy, 856, 858-859
diagnosis, 11 Bone tumors, benign, 949-966
Biliary tract disease, 75-98 bone-forming, 955-956
in cystic fibrosis, 181-183 common locations for, 950-952
Biliary tree, visualization of, in primary effects of bone on, 952
sclerosing cholangitis, 16 effects on bone, 952
Bilirubin, elevated, with cholestasis, 5 giant cell, 964
Biofeedback treatment, for encopresis and Langerhans’ cell histiocytosis, 964-965
soiling, 294 patterns and margins of bone
Birth trauma, child abuse vs, 1046 destruction in, 953
Bismuth subcitrate, for Helicobacter pylori periosteal reactions in, 954
infection, 226 staging of, 952
Bleeding time, medications affecting, 691 usual ages for, 950
screening laboratory test for, 690-691 malignant, 967-984
Blood, whole, for transfusion, Ewing’s sarcoma, 967-978. See also
improvements in, 794 Ewing's sarcoma.
Blood count, complete, interpretation of, malignant lesions resembling, 975-982
599-622. See also Complete blood count. alveolar rhabdomyosarcoma, 982
Blood loss, in newborns, characteristics of, bone lymphoma, 981
612 clear cell sarcoma of kidney, 981
Blood products, for transfusion, hepatoblastoma, 982
improvements in, 794-804 leukemia, 979, 981
granulocytes, 799 neuroblastoma, 979-980
plasma and cryoprecipitate, 797 retinoblastoma, 981-982
platelets, 797-799 osteosarcoma, 967-978. See also Osteo-
red blood cells, 794-796 sarcoma.
whole blood, 794 van Ness rotationplasty for, 975
pediatric, monitoring of, 799-800 Bowel, air-distended, in necrotizing
preparation and delivery of, 800-804 enterocolitis, 413
Blood smear, interpretation of, 603-604 anatomy and physiology of, 279-280
Blood transfusion, and graft-versus-host perforated, in necrotizing enterocolitis,
disease, 802-803 415
directed donations in, 804-806 resection of, adaptation process follow-
informed consent for, 805-806 ing, 535-537
limiting donor exposures, 803-804 Bowel training, for encopresis and soiling
Bloodstream, gas diffusion from, and prevention, 293
gastrointestinal gas accumulation, 491 Bowlegs, physiologic, 876
Blount’s disease, metaphyseal-diaphyseal management of, 878
angle in, 877 Brachial plexopathy, obstetric, and
Bone, drug-induced changes in, child neuromuscular disorders, 1130
abuse vs, 1049 Brachial plexus birth palsy, 927-929
long, growth of, 1115 Brachyspira aalborgi, and gastroenterocolitis,
metaphyseal area of, architecture of, 934 398
short, growth of, 1116 Bracing, for scoliosis, 892-893
Bone age, 1115 Bradycardia, gastroesophageal reflux in,
Bone cyst, aneurysmal, 962-963 200
and back pain, 915 Brain, in sickle-cell disease, 651-655
unicameral, 962-963 silent cerebral infarction, 654
Bone infections, 933-947 stroke, 652-654
Bone lymphoma, bone lesions with, 981 stroke prevention, 654
CUMULATIVE INDEX 1996 1433
Brain injury, and cerebral palsy, 1135-1136 classification of, 1136-1137
Breath tests, for Helicobacter pylori, 224-225 diagnosis of, 1137
Bronchitis, with gastroesophageal reflux, etiology of, 1135-1136
200 fecal incontinence with, 286
Bronchography, contrast, for stridor in treatment of, 1138-1145
neonates, 1343-1344 casting, 1139-1140
Buccal space, deep infection of, 1291, 1293 medication, 1141
Bunions, 1105-1106 neurosurgical management, 1141-1142
Byler’s disease, hepatocellular cholestasis orthopedic surgery, 1142-1145
with, 20 orthotics, 1140-1141
physical therapy, 1139
with congenital neuromuscular disor-
ders, 1130-1131
Caffey’s disease, child abuse vs, 1048 Cervical spine, disorders of, 919-926
Calcaneovalgus foot, 1094 atlantoaxial instability, 924-925
Calcium wasting, with cholestasis, 9 atlantoaxial rotatory subluxation,
Calicivirus, and gastroenterocolitis, 923-924
397-398 basilar impression, 925-926
Campylobacter, and secretory diarrhea, hemiatlas, 926
339-340 ; Klippel-Feil syndrome, 922-924
Carbohydrate, fermentation of, and occipitocervical synostosis, 926
gastrointestinal gas accumulation, os odontoideum, 922
491-492, 497 torticollis, 919-922
intolerance to, in chronic nonspecific di- orthopedic conditions of, 919-931
arrhea, 380 CFTR protein, in cystic fibrosis, 160-161,
malabsorption of, and chronic diarrhea, 165
315-318 Charcoal, activated, for gastrointestinal
and gastrointestinal gas accumulation, gas, 503
498 Charley horse, with repetitive overuse,
Carcinoid tumors, diarrhea caused by, 346 1025
Cardiac abnormalities, in Wilson’s disease, Chédiak-Higashi syndrome, and chronic
29 neutropenia, 786
Cardiac manifestations, of Crohn’s disease, Chelators, for Wilson’s disease, 30-31
261 Chemicals, toxic, and sensorineural
Cardiac output, distribution of, role of hearing loss, 1209-1210
glutamine in, 456 Child abuse, orthopedic aspects of,
Caroli’s disease, 83-84 1035-1051
Cartilage-forming tumors, benign, 956-959 differential diagnosis of, 1046-1049
chondroblastoma, 957 birth trauma, 1046
chondroma, 958-959 Caffey’s disease, 1048
chondromyxoid fibroma, 957-958 congenital insensitivity to pain,
osteochondroma, 956-957 1047-1048
Casting, for back pain, 912 congenital syphilis, 1047
for cerebral palsy, 1139-1140 copper deficiency, 1047
Catheter-related complications, in short drug-induced bone changes, 1049
bowel syndrome, long-term leukemia, 1048
management of, 543 normal variants, 1046
Cavus feet, 1105 osteogenesis imperfecta, 1046-1047
Cefpodoxime, for otitis media, 1170 rickets, 1047
Cefprozil, for otitis media, 1170 scurvy, 1048-1049
Ceftriaxone, for otitis media, 1170 vitamin A intoxication, 1048
Cefuroxime, for otitis media, 1170 fracture patterns in, 1042-1046. See
Central nervous system, ontogeny of, also Fracture patterns.
513-514 identification of problem, 1036-1042
Cerebral infarction, silent, in sickle cell history, 1036-1037
disease, 654 physical examination, 1037
Cerebral palsy, 1135-1150 radiographic dating of injuries,
associated deficiencies with, 1138 1038-1042
association with child abuse, 1035 radiographic evaluation, 1037-1038
brain injury and, 1135-1136 treatment of, 1049
1434 CUMULATIVE INDEX 1996
Child abuse (Continued) pathogenesis of, 1246
radiographic indications of, 1039-1042 Cholesterol, elevated, with cholestasis, 7
Chloride, intestinal secretion of, Cholesterol gallstones, cholelithiasis with,
physiology of, 438 90
Chloride channel defect, in cystic fibrosis, Cholestyramine, for erythropoietic
161-165 protoporphyria, 37
Chloride ions, intestinal transport of, Chondroblastoma, 957
short-chain fatty acid absorption and, Chondroma, 958-959
437 Chondromyxoid fibroma, 957-958
Choanal atresia, bilateral, in newborn, Chronic diarrhea. See Diarrhea.
1304 Chronic disease, in adults, anemia of,
Choking, and pediatric deaths, 1403-1404 624-626
causes of, 1404 Chronic neutropenia, 773-792. See also
Cholangiogram, in cholestasis diagnosis, Neutropenia.
12 Cisapride, for gastroesophageal reflux, 209
Cholangiopancreatography, endoscopic Cisplatin, and sensorineural hearing loss,
retrograde, in acute pancreatitis, 144 1210
Cholangitis, destructive, with Langerhans’ Clarithromycin, for otitis media, 1170
cell histiocytosis, 17 Clavicle, fracture of, 997
primary sclerosing, 15-17, 79-82 pseudarthrosis of, 1122
diagnosis of, 16, 80 congenital, 926-927
etiology of, 81 Clear cell sarcoma of kidney, bone lesions
neonatal, 79 with, 981
prevalence of, 15 “Clear liquid’ solutions, comparison of,
prognosis of, 81 447
treatment of, 81 Cleft ear, surgical correction of, 1241
recurrent, in Caroli’s disease, 84 Cleft palate speech, 1371-1374
Cholecystectomy, for cholelithiasis, 90-92 Cleidocraniodysostosis, 1122-1123
Cholecystitis, 91-92 Clindamycin, for otitis media, 1170
Choledochal cyst, 82-83, 128 Clostridium, and secretory diarrhea,
Cholelithiasis, 89-91 340-341
in cystic fibrosis, 181-182 Clostridium perfingens infection, and
Cholera toxin, and secretory diarrhea, 335 hemolytic anemia, 628
Cholestasis, chronic, 1-26 Clubfoot, 1097-1099
differential diagnosis of, 13-23 Coagulation times, laboratory diagnosis of,
hepatocellular, 20-23 691-692
in Alagille’s syndrome, 85-86 Cochlea, implant in, 1226
with ductal paucity, 17-20 normal, 1225
consequences of, 4-9 scala tympani obstruction in, 1225
definition and pathophysiology of, 1-3 Cochlear implants, 1217-1231
diagnosis of, 9-13 audiologist’s role in, 1219
hepatocellular, 2-3 complications of, 1229-1230
chronic, 20-23 decision for, criteria in, 1220
obstructive vs, 10 degree of hearing loss and, 1219
in cystic fibrosis, 179-180 hearing tests preceding, 1219-1220
intrahepatic, progressive familial, 20-22 multichannel, results with, 1227-1229
liver transplantation for, 103 pediatric program for, 1218
major causes of, 3 postoperative programming and train-
obstructive, 2 ing, 1223-1227
with extrahepatic biliary atresia, 75 preoperative assessment and candidacy
Cholesteatoma, 1245-1252 issues, 1218-1221
acquired, 1248-1251 radiographic evaluation for, 1220-1221
clinical presentation of, 1248-1249 speech development following, 1228
evaluation of, 1249-1250 success with, predictors of, 1229
management of, 1250-1251 surgery for, 1221-1223
pathogenesis, 1248 volume control of, 1226
congenital, 1245-1248 Colic, infantile, and intestinal gas
clinical presentation of, 1246-1247 accumulation, 503-505
evaluation of, 1247 Colipase, deficiency of, pancreatic
management of, 1247-1248 insufficiency in, 133
CUMULATIVE INDEX 1996
Colon, infectious gastroenterocolitis of, colonic appearance in, 268-269
398-402 diagnosis of, 263-267
Common bile duct, dilatation of, with differential, 267
choledochal cyst, 82 endoscopic and histologic, 265-267
distal, stricture of, in cystic fibrosis, 182- laboratory, 264-265
183 physical, 264
Communication disorders, 1375-1378 radiographic, 265-266
Complete blood count, band count in, 618 epidemiology of, 255-256
electric impedance cell counting, 601 gastrointestinal symptoms in, pathophys-
in newborns, 610-616 iology of, 259
interpretation of, 599-622 management of, 267-27
blood smear, 603-604 nutritional, 273
hematocrit values, 604 pharmacologic, 270-272
hemoglobin values, 604 psychiatric, 274
mean corpuscular volume, 606-608 surgical, 273-274
measurement, 600-602 pathogenesis of, 256-258
iron deficiency in, 614-616 pathology of, 258-259
platelets in, 616-617 prognosis in, 274
white blood cells in, 617-620 Cryoprecipitate, for transfusion,
Condylar fractures, management of, 1265 improvements in, 797
Congenital heart disease, and von Crypt cells, intestinal, migration of, 434
Willebrand disease, 6 Cryptocia, bilateral, surgical correction of,
Constipation. See also Enc. ,.e sis. 1240
and encopresis, outcome of, 294-295 Cup ear deformity, surgical correction of,
causes of, 283 1242
chronic nonspecific diarrhea vs, 379 Cyclosporine, drugs affecting level of, 111
functional, Hirschsprung’s disease vs, for liver transplantation, 110-111
283-284 for ulcerative colitis, 247-248
with or without encopresis, 280-282 Cystic fibrosis, 86-89, 157-196
in cystic fibrosis, 175 background on, 157-159
prevention of, 291-293 incidence, 158
Constriction bands, congenital, and limb newborn screening, 158-159
malformations, 1129 sweat test, 158
Copper deficiency, child abuse vs, 1047
ethmoid mucocele in, 1313
Copper storage disease, effect on liver, 28
free radicals and antioxidants in, 483-
Cordotomy, for vocal fold paralysis, 1370
484
Cortical desmoid, 961-962
gastrointestinal manifestations of, 167-
Corticosteroids, for Crohn’s disease,
176
270-271
gastrointestinal tract, 171-176
for idiopathic thrombocytopenic pur-
pancreas, 167-171
pura, 759
molecular and cellular aspects of, 159-
for liver transplantation, 112-113
167
topical, for sinusitis, 1307
Costal cartilage graft, for laryngotracheal basic gene defect, 159
stenosis, 1423-1425 CFTR protein, 160-161
Cow’s milk protein hypersensitivity, and chloride channel defect, 161-165
chronic diarrhea, 313-314 genotype analysis, 159-160
Craniofacial abnormalities, adenoidectomy phenotype-genotype correlations, 165-
for, 1326 167
Craniotomy, for intracranial hemorrhage, nutritional support in, 186--188
in idiopathic thrombocytopenic pancreatic pathophysiology in, 163
purpura, 766 sinusitis in, 1311-1312
Crescent sign, in Perthes disorder, 1058 somatic gene therapy for, 189-190
Cricoid split, for laryngotracheal stenosis, Cystic tumors, 959-963
1421-1422, 1424-1425 Cytokine(s), definition of, 559
Crohn's disease, 255-277 in anemia of inflammation, 631-632
clinical features of, 259-263 in mucosal immune system, 559-561
extraintestinal symptoms, 260-262 Cytomegalovirus infection, and
gastrointestinal symptoms, 260 gastroenterocolitis, 393-395
growth abnormalities and nutritional congenital, and sensorineural hearing
deficiencies, 262-263 loss, 1206
1436 CUMULATIVE INDEX 1996
Cytomegalovirus infection (Continued) intestinal motility and role of fat,
following liver transplantation, 116 382-383
transmission by transfusion, 801 intestinal secretion, 379-380
pathogenesis, 383-384
therapy for, 384-385
in human immunodeficiency virus infec-
DDAVP, for hemophilia, 718, 720 tion, 581-584
Débridement, surgical, for acute mechanisms of, 308
hematogenous osteomyelitis, 941-942 secretory, 333-353, 442-443. See also Se-
Decongestants, for sinusitis, 1306 cretory diarrhea.
Deep neck infection, 1277-1296. See also tumors causing, 344-350
under Neck. types of, 308
Dental malocclusion, adenoidectomy / with cholestasis, 8
tonsillectomy for, 1323 Diet, for Wilson's disease, 31
Dentoalveolar fracture, lateral view of, Dietary fiber, for encopresis and soiling
1260 prevention, 291
management of, 1265-1267 Dietary intolerance, and chronic diarrhea,
Desmopressin, for von Willebrand disease, 313-315
699 Digestion, stages of, 308
Developmental dysplasia, of hip, 829-848. Digestive enzymes, congenital absence of,
See also Hip. in acute diarrhea, 441
Diabetes mellitus, and chronic diarrhea, Diplegia, with cerebral palsy, management
322 of, 1145-1147
Diamond-Blackfan anemia, 606 Disc problems, and back pain, 904-907
Diaphyseal fracture, in child abuse, 1043 disc herniation, 904-905
Diarrhea, acute, mechanisms of, 440-442 discitis of childhood, 905-907
decreased absorption/ spondylolysis and spondylolisthesis,
malabsorption, 440-441 907
intestinal factors in, 441 Disimpaction, for encopresis and soiling,
luminal factors in, 442 290-291
chronic, and malabsorption, 307-331 Diuretics, loop, and sensorineural hearing
etiology of, 309 loss, 1210
anatomic lesions, 325-326 DNA polymerase analysis, in metabolic
carbohydrate malabsorption, 315- liver disease diagnosis, 45-47
318 Drugs, toxic, and sensorineural hearing
dietary, 313-315 loss, 1209-1210
endocrine disorders, 321-324 Dyskeratosis congenita, and chronic
hepatic disorders, 324-325 neutropenia, 786
immune deficiencies, 318-321 Dysphagia, in human immunodeficiency
infections, 310-311 virus infection, 579-581
parenteral, 312-313 Dysplasia, developmental, of hip, 829-848.
postinfectious, 313 See also Hip.
pseudomembranous enterocolitis,
326-327
tropical sprue, 311
vascular lesions, 325 Ear, malformations of, 1233-1244
Whipple’s disease, 312 trauma to, and sensorineural hearing
nonspecific, 375-390 loss, 1211-1212
characteristics of, 375-377 Eating disorders, adenoidectomy /
differential diagnosis of, 377-379 tonsillectomy for, 1323
constipation vs, 379 Education, for encopresis and soiling, 290
food intolerance vs, 378-379 Elbow, medial condyle of, traction
lactose intolerance vs, 378 apophysitis of, with repetitive
malabsorption vs, 377-378 overuse, 1016
parasites vs, 378 Electric impedance cell counting, for
prevention of, 385-386 complete blood count, 601-602
proposed mechanisms of, 379-384 Electrolyte(s), intestinal, absorption of,
carbohydrate intolerance, 380 435-438
fluid intake, 380 fluxes of, and oral rehydration
fruit juices, 381-382 solutions, 433-449
CUMULATIVE INDEX 1996 1437
physiology of, 435-439 Epithelial turnover, intestinal. in acute
oral solutions of, composition of, 443 diarrhea, 441
problems with, in short bowel syn- Epstein-Barr virus infection, following
drome, long-term management of, liver transplantation, 116
541-542 Erb’s palsy, of brachial plexus, 927
transport of, regulation of, 439-440 Erythroblastopenia, transient, of
Emesis, with gastroesophageal reflux, 199 childhood, 606
Encephalitis, herpes simplex, and Erythrocyte(s), abnormalities on blood
sensorineural hearing loss, 1208 smear, 603-604
Enchondroma, 958-959 Erythrocyte sedimentation rate, sequential
Encopresis, and soiling, 279-298 changes in, with inflammation, 627
investigations of, 288-289 Erythrocyte volume distribution, 602
management of, 290-294 Erythroid progenitor cells, parvovirus B19
outcome of, 294-295 tropism for, 811
Endocrine disorders, and chronic diarrhea, Erythropoiesis, effect of interferon-y on,
321-324 631
Endoscopic retrograde cholangiogram, in Erythropoietic protoporphyria, 35-38. See
cholestasis diagnosis, 12 also Protoporphyria.
Endoscopic retrograde Erythropoietin, for anemia of
cholangiopancreatography, in acute inflammation, 634
pancreatitis, 144 Escherichia coli, and gastroenterocolitis, 396,
Endoscopic therapy, for laryngotracheal 398-402
stenosis, 1421 and secretory diarrhea, 335-338
Endoscopy, for stridor in neonates, Esophageal biopsy, in gastroesophageal
1343-1344 reflux, 203-204
in gastroesophageal reflux, 203-204 Esophageal sphincter, lower, in
Endotracheal intubation, and gastroesophageal reflux, 198
laryngotracheal stenosis, 1418-1419 Ethmoiditis, clinical appearance of, 1298
Energy intake, in cystic fibrosis, 183-184 Evidence-based approach, to otitis media
Enteral feedings, aggressive, and treatment, 1165-1181
necrotizing enterocolitis, 419-420 Ewing's sarcoma, 967-978
Enteral nutrition, for short bowel biopsy of, 970
syndrome, 538-539 etiology and molecular genetics of, 971-
Enteric infection, in human 972
immunodeficiency virus infection, 580 general treatment principles for, 972
Enteric nervous system, ontogeny of, MR image of, 970
512-513 pathology of, 971
Enteric neuromuscular disease, and surgical margins for, 975
intestinal pseudo-obstruction, treatment for, 977-978
525-528 chemotherapy, 977-978
nervous system, 525-527 late effects of, 977-978
neuroendocrine environment, 527-528 radiotherapy, 977
smooth muscle, 527 surgical excision, 977
Enterocolitis, necrotizing, 409-432. See also External compression, and laryngotracheal
Necrotizing enterocolitis. stenosis, 1419
pseudomembranous, and chronic diar- External trauma, and laryngotracheal
rhea, 326-327 stenosis, 1419-1420
Enterocyte, antigen presentation by, model Extracorporeal membrane oxygenation,
of, 559 transfusions with, 804
Enterokinase, deficiency of, and chronic Extremity, pain in, with bone tumor, 949
diarrhea, 324
congenital, pancreatic insufficiency in,
Eosinophil(s), normal counts of, 619 Facial fractures, triangulation for, 1270
Eosinophilia, 618 Facial growth, 1255
Eosinophilic gastroenteritis, and chronic Facial trauma, 1253-1275
diarrhea, 323-324 epidemiology of, 1253-1254
Eosinophilic granuloma, 964-965 etiology of, 1254-1255
Epiphyseodesis, for limb length management of, emergency, 1256-1257
discrepancy, 856-857 examination, 1257
1438 CUMULATIVE INDEX 1996
Facial trauma (Continued) growing, reconstruction of, endopros-
mandibular fracture, 1264-1267 thesis for, 976
nasal fractures, 1261-1264 slipped capital epiphysis of, and hip
radiologic examination, 1258-1259 pain, 1060-1065
rigid fixation, 1256 Fenton reaction, in oxygen-free radical
surgical exposure, 1259-1261 generation, 472-473
nasal, in newborn, 1264 Fermentation, and gastrointestinal gas
reconstruction of, approaches to, 1273 accumulation, 491, 497
Factor VIII, porcine, for hemophilia, 725 Fetus, gastrointestinal motor activity in,
replacement therapy with, for hemo- 516
philia, 715-718 neonatal thrombocytopenia in, 743
guidelines for, 719 Fever, in osteomyelitis, 935
products available for, 716 Fiber, role in intestinal adaptation to
Factor VIII procoagulant, laboratory gastrointestinal disease, 458
evaluation of, for von Willebrand Fibroma, chondromyxoid, 957-958
disease, 693 nonossifying, 961
Factor IX, replacement therapy with, for ossifying, 960-961
hemophilia, 715-718 Fibrous cortical defect, 961
guidelines for, 719 Fibrous dysplasia, 959-960
products available for, 717 Fibrous tumors, 959-963
for hemophilia prophylaxis, 723-724 cortical desmoid, 961
Failure to thrive, adenoidectomy / fibrous cortical defect, 961
tonsillectomy for, 1324-1325 fibrous dysplasia, 959-960
in human immunodeficiency virus infec- nonossifying fibroma, 961
tion, 584 ossifying fibroma, 960-961
with cholestasis, 8, 21 Fibula, subperiosteal elevation of, 935
Familial microvillous atrophy, and chronic Fistula, perilymphatic, and sensorineural
diarrhea, 321 hearing loss, 1212
Fanconi anemia, 606 FK506, for liver transplantation, 112
thrombocytopenia with, 741 Flatfeet, definition of, 1099
Fat malabsorption, with cholestasis, 8 flexible, 1099-1100
Fatty acids, short-chain, role in intestinal painful, 1100-1101
adaptation to gastrointestinal disease, Fluid(s), intake of, in chronic nonspecific
457-459 diarrhea, 380
Fatty liver, in cystic fibrosis, 177 intestinal, absorption of, 435-438
Fecal continence, definition of, 280 problems with, in short bowel syn-
Fecal incontinence, definition of, 279 drome, long-term management of,
outcome of, 295 541-542
with or without constipation, 282-287 Fluorescence in situ hybridization, in
anorectal disorders, 286-287 metabolic liver disease diagnosis, 47
cerebral palsy and hypotonia, 286 Folate, recommendations for, in
Hirschsprung’s disease, 282-284 pregnancy, 1154
myelomeningocele, 285 Folic acid, in spina bifida prevention,
pseudo-obstruction, 284-285 1153-1154
rectal prolapse, 287 Food, reintroduction of, with oral
Fecal soiling, definition of, 279 rehydration therapy, 446
Feeding, and small intestinal motor Food intolerance, chronic nonspecific
activity, 524 diarrhea vs, 378-379
Feedings, thickened, for gastroesophageal Foot, deformities of, 1091-1111. See also
reflux, 206-207 Foot deformities.
Femoral head, containment of, in Perthes disorders of, with cerebral palsy, ortho-
disorder, 1059-1060 pedic surgery for, 1144-1145
luxation of, radiography of, 846 structure of, 1091-1093
Femoral shaft, fracture of, 1003-1007 Foot deformities, 1091-1111
management of, 1004-1007 anatomy and terminology of, 1091-1093
2 to 5 years of age, 1005-1006 at birth, 1093-1106
5 to 10 years of age, 1006 accessory navicular, 1103
10 to 12 years of age, 1007 bunions, 1105-1106
less than 2 years of age, 1005 calcaneovalgus, 1094
Femur, distal, problems with, 1082-1083 cavus feet, 1105